Integer (NYSE:ITGR) Hits New 52-Week High – Time to Buy?

Integer Holdings Co. (NYSE:ITGR)’s stock price reached a new 52-week high on Tuesday . The company traded as high as $140.91 and last traded at $140.20, with a volume of 3497 shares changing hands. The stock had previously closed at $139.49.

Analysts Set New Price Targets

A number of analysts have recently weighed in on ITGR shares. KeyCorp upped their target price on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research report on Tuesday, October 15th. Bank of America increased their price target on Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. Citigroup raised their target price on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. Oppenheimer began coverage on Integer in a research note on Tuesday, July 16th. They set an “outperform” rating and a $135.00 target price for the company. Finally, Truist Financial cut their price target on Integer from $150.00 to $147.00 and set a “buy” rating on the stock in a report on Friday, October 25th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $139.75.

Integer Stock Down 0.7 %

The firm has a market capitalization of $4.64 billion, a PE ratio of 43.09, a P/E/G ratio of 1.96 and a beta of 1.09. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The stock has a 50-day simple moving average of $128.63 and a 200-day simple moving average of $122.07.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.07. The company had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.27 earnings per share. Analysts forecast that Integer Holdings Co. will post 5.33 EPS for the current year.

Institutional Investors Weigh In On Integer

Several hedge funds have recently added to or reduced their stakes in ITGR. Driehaus Capital Management LLC lifted its stake in Integer by 62.5% during the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock worth $40,880,000 after purchasing an additional 135,750 shares during the last quarter. Eagle Asset Management Inc. bought a new stake in shares of Integer in the 3rd quarter valued at about $14,403,000. F M Investments LLC bought a new stake in shares of Integer in the 2nd quarter valued at about $11,143,000. Point72 Europe London LLP bought a new stake in shares of Integer in the 2nd quarter valued at about $6,241,000. Finally, Earnest Partners LLC lifted its stake in shares of Integer by 3.2% in the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after acquiring an additional 37,340 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.